title: 250 uM C1-MDB Treated - Primary Rat Hepatocytes
organism: Rattus norvegicus
description: This sample comprises primary rat hepatocytes from male Sprague Dawley rats treated with 250 uM C1-MDB, a c1-modified methylenedioxybenzene xenobiotic. The objective of this treatment is to investigate the impact of C1-MDB on gene expression and splicing mechanisms within hepatocytes. The chosen concentration is intended to provide insights into the cellular adaptations and potential toxicity induced by C1-MDB under laboratory conditions. The study aims to uncover the specific molecular pathways affected by C1-MDB, enhancing our understanding of its metabolic and regulatory effects on liver cells. Cells were kept under optimal culture conditions and RNA was harvested immediately after treatment to ensure the preservation of integrity for downstream analysis.